BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 16449618)

  • 1. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
    JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
    Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
    Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study.
    Traynor AE; Schroeder J; Rosa RM; Cheng D; Stefka J; Mujais S; Baker S; Burt RK
    Lancet; 2000 Aug; 356(9231):701-7. PubMed ID: 11085688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus.
    Petri M; Brodsky R
    JAMA; 2006 Feb; 295(5):559-60. PubMed ID: 16449623
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematopoietic stem cell transplantation for active systemic lupus erythematosus.
    Traynor A; Burt RK
    Rheumatology (Oxford); 1999 Aug; 38(8):767-72. PubMed ID: 10501431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
    Burt RK; Traynor AE; Pope R; Schroeder J; Cohen B; Karlin KH; Lobeck L; Goolsby C; Rowlings P; Davis FA; Stefoski D; Terry C; Keever-Taylor C; Rosen S; Vesole D; Fishman M; Brush M; Mujias S; Villa M; Burns WH
    Blood; 1998 Nov; 92(10):3505-14. PubMed ID: 9808541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus.
    Lisukov IA; Sizikova SA; Kulagin AD; Kruchkova IV; Gilevich AV; Konenkova LP; Zonova EV; Chernykh ER; Leplina OY; Sentyakova TN; Demin AA; Kozlov VA
    Lupus; 2004; 13(2):89-94. PubMed ID: 14995000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
    Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.
    Burt RK; Craig RM; Milanetti F; Quigley K; Gozdziak P; Bucha J; Testori A; Halverson A; Verda L; de Villiers WJ; Jovanovic B; Oyama Y
    Blood; 2010 Dec; 116(26):6123-32. PubMed ID: 20837778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation for systemic lupus erythematosus.
    Jayne D; Passweg J; Marmont A; Farge D; Zhao X; Arnold R; Hiepe F; Lisukov I; Musso M; Ou-Yang J; Marsh J; Wulffraat N; Besalduch J; Bingham SJ; Emery P; Brune M; Fassas A; Faulkner L; Ferster A; Fiehn C; Fouillard L; Geromin A; Greinix H; Rabusin M; Saccardi R; Schneider P; Zintl F; Gratwohl A; Tyndall A; ;
    Lupus; 2004; 13(3):168-76. PubMed ID: 15119545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.
    Burt RK; Balabanov R; Han X; Burns C; Gastala J; Jovanovic B; Helenowski I; Jitprapaikulsan J; Fryer JP; Pittock SJ
    Neurology; 2019 Oct; 93(18):e1732-e1741. PubMed ID: 31578302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review.
    Leone A; Radin M; Almarzooqi AM; Al-Saleh J; Roccatello D; Sciascia S; Khamashta M
    Autoimmun Rev; 2017 May; 16(5):469-477. PubMed ID: 28279836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.
    Alchi B; Jayne D; Labopin M; Demin A; Sergeevicheva V; Alexander T; Gualandi F; Gruhn B; Ouyang J; Rzepecki P; Held G; Sampol A; Voswinkel J; Ljungman P; Fassas A; Badoglio M; Saccardi R; Farge D;
    Lupus; 2013 Mar; 22(3):245-53. PubMed ID: 23257404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation.
    Traynor AE; Corbridge TC; Eagan AE; Barr WG; Liu Q; Oyama Y; Burt RK
    Chest; 2005 May; 127(5):1680-9. PubMed ID: 15888846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.
    Loh Y; Oyama Y; Statkute L; Traynor A; Satkus J; Quigley K; Yaung K; Barr W; Bucha J; Gheorghiade M; Burt RK
    Bone Marrow Transplant; 2007 Jul; 40(1):47-53. PubMed ID: 17483845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.